Madrigal Pharmaceuticals, Inc. MDGL Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s common stock, shares, outstanding?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported common stock, shares, outstanding of $23.04M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s common stock, shares, outstanding changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s common stock, shares, outstanding increased by 3.8% year-over-year, from $22.19M to $23.04M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s common stock, shares, outstanding?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s common stock, shares, outstanding has grown at a 8.1% compound annual growth rate (CAGR), from $15.51M to $22.84M.